Nephrogen

Helex

This biotechnology company develops gene editing therapeutics and lipid nanoparticle delivery platforms for patients suffering from genetic kidney diseases.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

ZipBio

The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.

Nerai

This company develops specific genome editors using an artificial intelligence protein discovery platform for biotechnology firms and patients with rare inherited diseases.

Nionyx Bio

The company develops adeno-associated virus gene therapies for patients with genetic kidney diseases.

Neurogene Inc

This company develops genetic medicines and gene therapies to treat patients and families affected by rare neurological diseases including Rett syndrome and Batten disease.

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.

Purespring

Purespring develops gene therapies targeting podocyte cells to treat chronic kidney diseases for patients with conditions such as IgA nephropathy and Alport syndrome.